| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.166 | 28.205 | 22.470 | 60 | 1.245 | 5.785 | 17.480 | 22.927 | 3.396 | 0 |
| Total Income - EUR | 7.168 | 28.234 | 22.470 | 60 | 1.245 | 5.785 | 17.480 | 22.951 | 3.396 | 0 |
| Total Expenses - EUR | 2.215 | 1.481 | 910 | 145 | 702 | 251 | 1.128 | 3.166 | 3.373 | 29 |
| Gross Profit/Loss - EUR | 4.953 | 26.754 | 21.560 | -85 | 543 | 5.535 | 16.351 | 19.785 | 24 | -29 |
| Net Profit/Loss - EUR | 4.738 | 25.907 | 20.886 | -87 | 506 | 5.372 | 15.838 | 19.201 | -104 | -29 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
Check the financial reports for the company - Oncocircuit Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 15.554 | 26.508 | 20.938 | 11.193 | 11.517 | 16.701 | 17.311 | 19.976 | 3.760 | 3.710 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 85 | 83 | 1.432 | 1.428 | 1.420 |
| Receivables | 8.942 | 3.746 | 9.887 | 10.392 | 10.191 | 11.364 | 15.964 | 16.097 | 973 | 968 |
| Cash | 6.611 | 22.762 | 11.051 | 802 | 1.326 | 5.253 | 1.264 | 2.447 | 1.359 | 1.322 |
| Shareholders Funds | 15.391 | 25.961 | 20.938 | 11.193 | 11.482 | 16.637 | 15.886 | 19.250 | 3.586 | 3.536 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 163 | 547 | 0 | 0 | 34 | 64 | 1.425 | 726 | 174 | 173 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oncocircuit Srl